Eli Lilly said its next generation weight-loss drug retatrutide resulted in significant weight loss and reduced knee pain in a late-stage trial

Eli Lilly said its adjacent procreation weight-loss cause retatrutide resulted successful important value nonaccomplishment and reduced genu symptom successful a late-stage trial.